title: Patient rationale in selecting androgen deprivation (PRISAD): do we give patients what they want?
abstract: To assess patient rationale in selecting androgen deprivation, structured telephone interviews were conducted on consecutive patients on androgen deprivation over a 17-year period. The majority of these patients have stable disease that require long-term follow-up with 6-monthly PSA estimations. Synchronous PSA check with depot injections are preferred by majority of patients and longer intervals between the depot administrations are preferable due to perceived less needle pain. This study highlights for the first time patients' preferences for synchronous PSA check with their depot injections and a longer interval between the depot administrations due to perceived less needle pain.
authors.affiliation: Department of Urology and Oncology, Wollongong Hospital, Wollongong, NSW, Australia. ericchg@hotmail.com
authors.forename: Eric
authors.initials: E
authors.lastname: Chung
authors.forename: Hunter
authors.initials: H
authors.lastname: Watt
authors.forename: Amanda
authors.initials: A
authors.lastname: Glasgow
authors.forename: Tim
authors.initials: T
authors.lastname: Skyring
mesh_terms: D000328:Adult; D000368:Aged; D000726:Androgen Antagonists / Q000008:administration & dosage*; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage*; D006801:Humans; D007407:Interviews as Topic; D008297:Male; D008875:Middle Aged; D010358:Patient Participation; D011379:Prognosis; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000097:blood / Q000188:drug therapy* / Q000523:psychology; D011788:Quality of Life; D018570:Risk Assessment; D015996:Survival Rate; D055815:Young Adult
chemical_list: D000726:Androgen Antagonists; D018931:Antineoplastic Agents, Hormonal; D017430:Prostate-Specific Antigen